For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts

News Release
Trump’s views on Tylenol shouldn’t supersede doctor advice
President Trump railed against Tylenol (acetaminophen) in a press conference this week, imploring, in particular, pregnant women and babies to not take (or be administered)…

Blog
Free the Economy podcast: Empowering patients with Vance Ginn
In this week’s episode we cover potential changes to quarterly reporting for public companies, state-level AI regulations, spiking gas prices in…

Blog
The current state of pharmaceutical tariffs
Background Amid the Trump trade upheaval, pharmaceutical products receive different treatment than many other US imports. Pharmaceuticals are treated differently for reasons such as their…